Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Inventory (2016 - 2025)

Nephros has reported Inventory over the past 16 years, most recently at $3.2 million for Q4 2025.

  • Quarterly results put Inventory at $3.2 million for Q4 2025, up 23.59% from a year ago — trailing twelve months through Dec 2025 was $3.2 million (up 23.59% YoY), and the annual figure for FY2025 was $3.2 million, up 23.59%.
  • Inventory for Q4 2025 was $3.2 million at Nephros, up from $2.7 million in the prior quarter.
  • Over the last five years, Inventory for NEPH hit a ceiling of $5.1 million in Q2 2021 and a floor of $2.0 million in Q1 2025.
  • Median Inventory over the past 5 years was $3.0 million (2024), compared with a mean of $3.3 million.
  • Biggest five-year swings in Inventory: plummeted 54.42% in 2023 and later soared 36.64% in 2024.
  • Nephros' Inventory stood at $4.5 million in 2021, then fell by 29.34% to $3.2 million in 2022, then decreased by 21.66% to $2.5 million in 2023, then rose by 5.87% to $2.6 million in 2024, then increased by 23.59% to $3.2 million in 2025.
  • The last three reported values for Inventory were $3.2 million (Q4 2025), $2.7 million (Q3 2025), and $2.2 million (Q2 2025) per Business Quant data.